Gw501516 20mg Dragon Pharma

£154.00

GW501516 is a peroxisome proliferator-activated receptor delta (PPARδ) agonist studied extensively in metabolic research and fatty acid oxidation pathways.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Gw501516 20mg Dragon Pharma
Gw501516 20mg Dragon Pharma
£154.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview of GW501516 Compound

GW501516 is a peroxisome proliferator-activated receptor delta (PPARδ) agonist extensively researched for its effects on metabolic pathways and cellular energy regulation. This compound, also known as Cardarine, functions as a selective modulator of PPARδ nuclear receptors, which play crucial roles in fatty acid oxidation and glucose metabolism in laboratory models. Researchers from Stroid UK Shop can examine this compound’s unique mechanism of action in various experimental protocols designed to investigate metabolic function.

The compound demonstrates significant activity in preclinical studies examining energy expenditure pathways, making it valuable for researchers investigating metabolic disorders and cellular bioenergetics. When studying compounds from the broader Endurobol GW501516 category, scientists often analyse GW501516’s interactions with mitochondrial function and fatty acid beta-oxidation processes. This Dragon Pharma formulation provides consistent potency for laboratory investigations requiring reliable compound characteristics.

Laboratory Applications and Research Methodology

Research applications for GW501516 include studies on PPARδ receptor activation, metabolic syndrome models, and cellular energy regulation mechanisms. Scientists frequently investigate this compound alongside other metabolic modulators and compounds from the SARMs research category to examine comparative receptor binding profiles and downstream signalling pathways. The compound’s oral bioavailability in preclinical models makes it suitable for various experimental designs requiring consistent dosing protocols.

Laboratory studies often examine GW501516’s effects on gene expression patterns related to fatty acid metabolism, particularly in hepatic and skeletal muscle tissue models. Researchers also investigate its interactions with other metabolic regulators and compounds from the peptides research section to study comprehensive metabolic pathway modulation. The compound’s stability profile allows for extended experimental protocols examining both acute and chronic exposure effects.

Technical Specifications

GW501516 20mg Dragon Pharma Technical Data
Chemical Name GW501516 (Cardarine)
CAS Number 317318-70-0
Molecular Formula C₂₁H₁₈F₃NO₃S₂
Molecular Weight 453.50 g/mol
Concentration 20mg per unit
Manufacturer Dragon Pharma
Storage Requirements Room temperature, protect from light

Research Compliance Information

This GW501516 compound is manufactured exclusively for in-vitro laboratory research applications and scientific investigation purposes. The product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper safety protocols and regulatory compliance when handling this material in their institutional research facilities.

Related